Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications

American Journal of Kidney Diseases

Volumn 34, Issue 6, 1999, Pages 973-995

  Bianchi, S ^a   Bigazzi, R ^a   Campese, V M ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Hypertension; Microalbuminuria; Renal failure

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRENDIPINE;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REVIEW;

EID: 0032746704     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70002-8     Document Type: Article

References (307)

1. H Keen C Chlouverakis An immunoassay method for urinary albumin at low concentrations Lancet 1 1963 913 914
2. HMJ Krans M Porta H Keen Diabetes Care and Research in Europe: The St Vincent Declaration Action Programme 1992 World Health Organization Copenhagen, Denmark 29 32
3. GC Viberti RD Hill RD Jarret A Argyropoulos U Mahmud H Keen Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 1 1982 1430 1432
4. HH Parving B Oxenboll PA Svendsen JS Christensen AR Andersen Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion Acta Endocrinol 100 1982 550 555
5. CE Mogensen CK Christensen Predicting diabetic nephropathy in insulin-dependent patients New Engl J Med 31 1984 89 93
6. DM Nathan Long-term complications of diabetes mellitus N Engl J Med 328 1993 1676 1685
7. SL Jones GC Viberti Hypertension and microalbuminuria as predictors of diabetic nephropathy Diabetes Metab 15 1989 327 332
8. ER Mathiensen N Saurbrey E Hommel HH Parving Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus Diabetologia 29 1986 640 643
9. O Wirta A Pasternack J Mustonen H Oksa T Koivula H Helin Albumin excretion rate and its relation to kidney disease in non–insulin-dependent diabetes mellitus J Intern Med 237 1995 367 373
10. CE Mogensen Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310 1984 356 360
11. JW Messent TG Elliot RG Hill RJ Jarret H Keen GC Viberti Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three-year follow-up study Kidney Int 41 1992 836 839
12. RJ Jarret GC Viberti A Argyropoulos RD Hill U Mahmud TJ Murrels Microalbuminuria predicts mortality in non–insulin-dependent diabetics Diabet Med 1 1984 17 19
13. A Schmitz M Vaeth Microalbuminuria: A major risk factor in non–insulin-dependent diabetes. A ten-year follow-up study of 503 patients Diabet Med 5 1988 126 134
14. CE Mogensen Antihypertensive treatment inhibiting the progression of diabetic nephropathy Acta Endocrinol 238 1980 103 108
15. CI Johnson ME Cooper GM Nicolls Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes J Hypertens 10 1992 393 397
16. CE Mogensen KW Hansen NN Pedersen CK Christensen Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM Diabetes Care 4 suppl 4 1991 S13 S26
17. GC Viberti CE Mogensen LC Groop JF Pauls for the European Microalbuminuria Captopril Study Group Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria JAMA 271 1994 245 326
18. TBB Wiegmann KG Herron AM Chonko ML MacDougall WV Moore Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients Diabetes 41 1992 62 67
19. T Baba S Murabayashi K Takebe Comparison of the renal effects of angiotensin-converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non–insulin-dependent) diabetic patients with microalbuminuria: A randomized controlled trial Diabetologia 32 1989 40 44
20. M Ravid H Savin I Jutrin T Bental B Katz M Lishner Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients Ann Intern Med 118 1993 577 581
21. M Marre M Hallab A Billiard JJ Le Jeune F Bled A Girault P Fressinaud Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes J Cardiovasc Pharmacol 18 suppl 2 1991 S165 S168
22. US Renal Data System: USRDS 1996 Annual Data Report Am J Kidney Dis 28 1996 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, Maryland S34 S47 suppl 2
23. O Eshoj B Feldt-Rasmussen ML Larsen CE Mogensen Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria Diabet Med 4 1987 531 533
24. DJ Rowe H Bagga PB Betts Normal variations in rate of albumin excretion and albumin to creatinine ratios in overnight and day-time urine collections in non-diabetic children BMJ 291 1985 693 694
25. DL Cohen CF Close GC Viberti The variability of overnight urinary albumin excretion in insulin dependent diabetic and normal subjects Diabet Med 4 1987 437 440
26. MA James MD Fotherby JF Potter Microalbuminuria in elderly hypertensives: Reproducibility and relation to clinic and ambulatory blood pressure J Hypertens 12 1994 309 314
27. VR Collins GK Dowse CF Finch PW Zimmet AW Linnane Prevalence and risk factors for micro and macroalbuminuria in diabetic subjects and entire population of Nauru Diabetes 38 1989 1602 1610
28. PA Metcalf RK Scragg Epidemiology of microalbuminuria in the general population J Diabetes Complications 8 1994 157 163
29. PA Metcalf JR Baker RK Scragg E Dryson AJ Scott CJ Wild Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity Diabetes Care 16 1993 1485 1493
30. LM Gerber C Shmukler MH Alderman Differences in urinary albumin excretion rate between normotensive and hypertensive white and nonwhite subjects Arch Intern Med 152 1992 373 377
31. GC Viberti JD Walker J Pinto Diabetic nephropathy KG Alberti RA De Fronzo H Keen P Zimmet International Textbook of Diabetes Mellitus 1992 Wiley & Son Chichester 1267 1328
32. N Lokkegaard I Haupter TB Kristensen Microalbuminuria in obesity Scand J Urol Nephrol 26 1992 275 278
33. W Gatling D Rowe RD Hill Microalbuminuria: An appraisal of assay techniques and urine collection procedures for measuring urinary albumin at low concentrations CE Mogensen The Kidney and Hypertension in Diabetes Mellitus 1988 Martinus Nijjoff Boston, MA 41 49
34. GC Viberti RJ Jarret M McCartney H Keen Increased glomerular permeability to albumin induced by exercise in diabetic subjects Diabetologia 14 1978 293 300
35. A Mohamed T Wilkin BA Leatherdale D Rowe Response of urinary albumin to submaximal exercise in newly diagnosed non-insulin dependent diabetes BMJ 288 1984 1342 1343
36. G Montagna C Buzio C Calderini P Quaretti L Migone Relationship of proteinuria and albuminuria to posture and to urine collection period Nephron 35 1983 143 144
37. JNW West P Gosling SB Dimmitt WA Littler Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure Clin Sci 81 1991 373 377
38. PA Metcalf JR Baker RK Scragg E Dryson AJ Scott CJ Wild Albuminuria in people at least 40 years old: Effect of alcohol consumption, regular exercise, and cigarette smoking Clin Chem 39 1993 1793 1797
39. MM Gould V Mohamed Ali SA Goubet JS Yudkin AP: Haines Microalbuminuria: Association with height and sex in non diabetic subjects BMJ 306 1993 240 242
40. AS Hutchison KR Paterson Collecting urine for microalbumin assay Diabet Med 5 1988 527 532
41. CDA Stehouwer HRA Fischer WHL Hackeng GJH den Ottolander Identifying patients with incipient diabetic nephropathy. Should 24-hr urine collections be used? Arch Intern Med 150 1990 373 375
42. CT Cowell S Rogers M Silink First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes Diabetologia 29 1986 97 99
43. A Hogholm LE Bang KS Kristensen JW Nielsen J Holm Microalbuminuria in 411 untreated individuals with established hypertension, white-coat hypertension, and normotension Hypertension 24 1994 101 105
44. SM Marshall Screening for microalbuminuria: Which measurement? Diabet Med 8 1991 706 711
45. SJ Schwab RL Christensen K Dougherty S Klahr Quantitation of proteinuria by the use of protein-to-creatinine ratios in a single urine sample Arch Intern Med 147 1987 943 944
46. PH Bennet S Haffner BL Kasiske WF Keane CE Mogensen HH Parving MW Steffes GE Stricker Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendation to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation Am J Kidney Dis 25 1995 107 112
47. W Gatling C Knight RD Hill Screening for early diabetic nephropathy: Which sample to detect microalbuminuria Diabet Med 2 1985 451 455
48. JEA Howey MCK Browning CG Frazer Biologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs Am J Kidney Dis 13 1989 35 37
49. AS Hutchison DSJ O'Reilly AC MacCuish Albumin excretion rate, albumin concentration and albumin/creatinine ratio compared for screening diabetics for slight albuminuria Clin Chem 34 1988 2019 2021
50. SJ Connel S Hollis KL Tieszen JR McMurray T Dornan Gender and the clinical usefulness of the albumin-creatinine ratio Diabet Med 11 1994 32 36
51. PL Poulsen CE Mogensen Evaluation of a new semiquantitative stix for microalbuminuria Diabetes Care 18 1995 732 733
52. G Slama J Boillot N Desplanque M Letanoux Bedside estimation of microalbuminuria Lancet 1 1985 1338 1339
53. SM Marshall PA Shearing KG Alberti Micral-test strips evaluated for screening for microalbuminuria Clin Chem 38 1992 588 591
54. CE Mogensen GC Viberti E Peheim D Kutter C Hasslacher W Hoffmann R Renner M Bojestig PL Poulsen G Scott J Thoma J Kuefer B Nilsson B Gambke P Mueller J Steinbiss KD Willamowski Multicenter evaluation of the Micral-Test II strip, an immunologic rapid test for the detection of microalbuminuria Diabetes Care 20 1997 1642 1646
55. ND Olivarius CE Mogensen Danish general practitioners' estimation of urinary albumin concentration in the detection of proteinuria and microalbuminuria Br J Gen Pract 45 1995 71 73
56. DM Miles CE Mogensen HJG Gundersen Radioimmunoassay for urinary albumin using a single antibody Scand J Clin Lab Invest 26 1970 5 11
57. AM Teppo Immunoturbidimetry of albumin and immunoglobulin G in urine Clin Chem 28 1982 1359 1361
58. GF Watts JE Bennet DJ Rowe RW Morris W Gatling KM Shaw A Polak Assessment of immunochemical methods for determining low concentration of albumin in urine Clin Chem 32 1986 1544 1548
59. EM Kearney JN Mount GF Watts BM Slavin PRN Kind Simple immunoturbidimetric method for determining urinary albumin at low concentrations using the Cobas Bio centrifugal analyser Clin Pathol 40 1987 465 468
60. BA Fielding DA Price CA Houlton Enzyme immunoassay for urine albumin Clin Chem 29 1983 355 357
61. A Puri R Casburn-Budd V Eisen JDH Slater Simpler measurements of albumin in urine or plasma Clin Chem 31 1985 1241 1242
62. A Erman M Rabinov J Rosenfeld Albumin determination in frozen urines underestimated results Clin Chim Acta 174 1988 255 261
63. LD Elving JA Bakkeren MJ Jansen CM de Kat Angelino E de Nobel PJ van Munster Screening for microalbuminuria in patients with diabetes mellitus: Frozen storage of urine samples decreases their albumin content Clin Chem 35 1989 308 310
64. SE Manley ME Burton KE Fisher CA Cull RC Turner Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine sample stored at –20°C Clin Chem 38 1992 2294 2299
65. I Osberg HP Chase SK Garg A DeAndrea S Harris R Hamilton G Marshall Effects of storage time and temperature on measurement of small concentrations of albumin in urine Clin Chem 366 1990 1428 1430
66. DJF Rowe A Dawnay GF Watts Microalbuminuria in diabetes mellitus: Review and recommendations for the measurement of albumin in urine Ann Clin Biochem 27 1990 297 313
67. ACG Collins M Sethi FA MacDonald D Brown GC Viberti Storage temperature and differing methods of sample preparation in the measurement of urinary albumin Diabetologia 36 1993 993 997
68. WB Kannel MJ Stampfer WP Castelli J Verter The prognostic significance of proteinuria: The Framingham Study Am Heart J 108 1984 1347 1352
69. CJ Bulpitt DG Beevers A Butler EC Coles D Hunt AD Munro-Faure RB Newson PW O'Riordan JC Petrie B Rajagopalan The survival of treated hypertensive patients and their causes of death: A report from the DHSS Hypertensive Care Computing Project (DHCCP) J Hypertens 4 1986 93 99
70. A Lewin D Blaufox H Castle G Entwisle H Langford Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-Up Program Arch Intern Med 145 1985 424 427
71. HH Parving HE Jensen CE Mogensen PE Evrin Increased urinary albumin excretion in benign essential hypertension Lancet 1 1974 231 237
72. EB Pedersen CE Mogensen Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate and renal plasma flow in patients with essential hypertension Scand J Clin Lab Invest 36 1976 231 237
73. R Bigazzi S Bianchi VM Campese GL Baldari Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension Nephron 61 1992 94 97
74. J Redon Y Liao JV Lozano A Miralles E Baldo Factors related to the presence of microalbuminuria in essential hypertension Am J Hypertens 7 1994 801 807
75. JG Sprangler RA Bell JH Summerson JC Konen Correlates of abnormal urinary albumin excretion rates among primary care patients with essential hypertension J Am Board Fam Pract 10 1997 180 184
76. B Agrawal A Berger K Wolf FC Luft Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension J Hypertens 14 1996 223 228
77. P Gosling DG Beevers Urinary albumin excretion and blood pressure in the general population Clin Sci 76 1989 39 42
78. EM Damsgaard A Froland OD Jorgensen CE Mogensen Microalbuminuria as predictor of increased mortality in elderly people BMJ 300 1990 297 300
79. GF Watts RW Morris K Khan A Polak Urinary albumin excretion in healthy adult subjects: Reference values and some factors affecting their interpretation Clin Chim Acta 172 1988 191 198
80. A James MB Fotherby JF Potter Screening tests for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure Clin Sci 88 1995 185 190
81. JA Opsahl PA Abraham CE Halstenson WF Keane Correlation of office and ambulatory blood pressure measurements with urinary albumin and N -acetyl-beta-D-glucosaminidase excretions in essential hypertension Am J Hypertens 1 1988 117 120
82. PH Winocour J Harland JP Millar MF Laker KG Alberti Microalbuminuria and associated risk factors in the community Atherosclerosis 93 1992 71 81
83. JS Jensen K Borch Johnsen G Jensen B Feldt Rasmussen Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria Atherosclerosis 112 1995 245 252
84. S Giaconi C Levanti E Fommei F Innocenti G Seghieri L Palla C Palombo S Ghione Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension Am J Hypertens 2 1989 259 261
85. G Cerasola S Cottone G Mule E Nardi MT Mangano G Andronico A Contorno M Li Vecchi P Gaglione F Renda G Piazza V Volpe A Lisi L Ferrara N Panepinto R Riccobene Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension J Hypertens 14 1996 915 920
86. S Bianchi R Bigazzi G Baldari GP Sgherri VM Campese Diurnal variation of blood pressure and microalbuminuria in essential hypertension Am J Hypertens 7 1994 23 29
87. J Redon Y Liao JV Lozano A Miralles JM Pasqual RS Cooper Ambulatory blood pressure and microalbuminuria in essential hypertension: Role of circadian variability J Hypertens 12 1994 947 953
88. G Berrut M Hallab B Bouhanick AM Chameau M Marre P Fressinaud Value of ambulatory blood pressure monitoring in type I (insulin-dependent) diabetic patients with incipient diabetic nephropathy Am J Hypertens 7 1994 222 227
89. TB Weigmann KG Herron AM Chonko MI Mac Dougall WV Moore Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus Diabetes 39 1990 1556 1560
90. T Almdal K Norgaard B Feldt-Rasmussen T Deckert The predictive value of microalbuminuria in IDDM: A five-year follow-up study Diabetes Care 17 1994 120 125
91. R Fogari A Zoppi GD Malamani P Lazzari B Albonico L Corradi Urinary albumin excretion and nocturnal blood pressure in hypertensive patients with type II diabetes mellitus Am J Hypertens 7 1994 808 813
92. S Equiluz-Bruck C Schnack HP Kopp G Schernthaner Non dipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus Am J Hypertens 9 1996 1139 1143
93. PL Poulsen KW Hansen CE Mogensen Ambulatory blood pressure in the transition from normo to microalbuminuria. A longitudinal study in IDDM patients Diabetes 43 1994 1248 1253
94. KW Hansen PL Poulsen CE Mogensen Ambulatory blood pressure and abnormal albuminuria in type I diabetic patients Kidney Int Suppl 45 1994 S34 S40
95. S Nielsen A Schmitz PL Poulsen KW Hansen CE Mogensen Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study Diabetes Care 18 1995 1434 1441
96. M Sokolow D Werdegar HK Kain A Hinman Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension Circulation 34 1966 279 298
97. WB White P Schulman EJ MacCabe Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension JAMA 261 1989 873 877
98. LM Prisant AA Carr Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass Am J Hypertens 3 1990 81 89
99. TG Pickering R Devereux Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk Am Heart J 114 1987 925 928
100. P Verdecchia G Schillaci M Guerrieri C Gatteschi G Benemio F Boldrini Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension Circulation 81 1990 528 536
101. K Sluniade A Kawamoto K Matsubayashi T Ozawa Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure Hypertension 16 1990 692 699
102. K Shimada A Kawamoto K Matsubayashi M Nishinaga S Kimura T Ozawa Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension J Hypertens 10 1992 875 878
103. RM Edwards Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels Am J Physiol 244 1983 F526 F534
104. LD Dworkin I Ichikawa BM Brenner Hormonal modulation of glomerular function Am J Physiol 244 1983 F95 F104
105. LD Dworkin Effects of calcium antagonists on glomerular hemodynamics and structure in experimental hypertension Am J Kidney Dis 5 suppl 1 1991 S89 S93
106. R Loutzenhiser M Epstein Effects of calcium antagonists on renal hemodynamics Am J Physiol 249 1985 F619 F629
107. L Raij X Chiou R Owens B Wrigley Therapeutic implication of hypertension-induced glomerular injury: Comparison of enalapril and the combination of hydralazine-reserpine-hydrochlorothiazide Am J Med 9 1985 37 41
108. TH Hostetter JL Olson HG Rennke MA Venkatachalam BM Brenner Hyperfiltration in remnant nephrons: A potential adverse response to renal ablation Am J Physiol 241 1981 F85 F93
109. LG Feld JB Van Liew RG Galaske JW Boylan Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat Kidney Int 12 1977 332 343
110. S Azar MA Johnson J Scheinman L Bruno L Tobian Regulation of glomerular capillary pressure and filtration rate in young Kyoto hypertensive rats Clin Sci 56 1979 203 209
111. L Raij S Azar WF Keane Role of hypertension in progressive glomerular immune injury Hypertension 7 1985 398 404
112. S Azar C Limas J Iwai D Weller Single-nephron dynamics during high Na+ intake and early hypertension in Dahl rats Jpn Heart J 20 suppl 1 1979 S138 S140
113. T Takenaka H Forster A De Micheli M Epstein Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats Circ Res 71 1992 471 480
114. LD Dworkin TH Hostetter HG Rennke BM Brenner Evidence for hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension J Clin Invest 73 1984 1448 1461
115. RW Steiner BJ Tucker LC Gushwa J Gifford CB Wilson RC Blantz Glomerular hemodynamics in moderate Goldblatt hypertension in rat Hypertension 4 1982 51 57
116. S Azar MA Johnson B Hertel L Tobian Single-nephron pressures, flow and resistances in hypertensive kidneys with nephrosclerosis Kidney Int 12 1977 28 40
117. G Bianchi D Cusi E Guidi Renal hemodynamics in human subjects and in animals with genetic hypertension during the prehypertensive stage Am J Nephrol 3 1983 73 79
118. SB Levy LB Talner MN Coel R Holle RA Stone Renal vasculature in essential hypertension: Racial differences Ann Intern Med 88 1978 12 16
119. ED Frohlich FH Messerli FG Dunn W Oigman HO Ventura K Sungaard-Riise Greater renal vascular involvement in the black patient with essential hypertension: A comparison of systemic and renal hemodynamics in black and white patients Miner Electrolyte Metab 10 1984 173 177
120. J Lowenstein ER Beranbaum H Chasis DS Baldwin Intrarenal pressure and exaggerated natriuresis in essential hypertension Clin Sci 38 1970 359 374
121. VM Campese M Parise F Karubian R Bigazzi Abnormal renal hemodynamics in black salt-sensitive patients with hypertension Hypertension 18 1991 805 812
122. R Bigazzi S Bianchi D Baldari G Sgherri G Baldari VM Campese Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors Hypertension 23 1994 195 199
123. RE Easterling Racial factors in the incidence of causation of end-stage renal disease (ESRD) Trans Am Soc Artif Intern Organs 23 1977 28 32
124. HP Dustan JJ Curtis RG Luke SG Rostand Systemic hypertension and the kidney in black patients Am J Cardiol 60 1987 731 771
125. SG Rostand G Brown KA Kirk EA Rutsky HP Dustan Renal insufficiency in treated essential hypertension N Engl J Med 320 1989 684 688
126. GH Williams NK Hollenberg “Sodium-sensitive” essential hypertension. Emerging insights into pathogenesis and therapeutic implications Contemp Nephrol 3 1985 303 331
127. NK Hollenberg T Moore D Shoback J Redgrave S Rabinowe GH Williams Abnormal renal sodium handling in essential hypertension Am J Med 81 1986 412 418
128. R Baldoncini C Bellini C Desideri C De Angelis C Ferri A Santucci Elevated albumin excretion in nonmodulating essential hypertensive patients Nephron 76 1997 264 269
129. R Bigazzi S Bianchi G Baldari VM Campese Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin Am J Hypertens 9 1996 24 32
130. I Zavaroni P Coruzzi L Bonini GL Mossini L Musiari P Gasparini M Fantuzzi GM Reaven Association between salt sensitivity and insulin concentrations in patients with hypertension Am J Hypertens 8 1995 855 858
131. AB Weder Red-cell lithium sodium countertransport and renal lithium clearance in hypertension N Engl J Med 314 1986 198 201
132. VM Campese Salt-sensitivity in hypertension. Renal and cardiovascular implications Hypertension 23 1994 531 550
133. IMS van Hooft DE Grobbee FHM Derkx PW de Leeuw ADH Schalekamp A Hofman Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents N Engl J Med 324 1991 1305 1311
134. A Losito F Fortunati I Zampi A Del Favero Impaired renal functional reserve and albuminuria in essential hypertension BMJ 296 1988 1562 1564
135. C Buzio G Regolisti F Perazzoli A Mutti E Bergamaschi B Borghetti Renal effects of nifedipine and captopril in patients with essential hypertension and reduced renal reserve Hypertension 24 1994 763 769
136. FB Gabbai Renal reserve in patients with high blood pressure Semin Nephrol 15 1995 482 487
137. J Ribstein G du Cailar A Mimran Combined renal effects of overweight and hypertension Hypertension 26 1995 610 615
138. A Kverneland B Feldt-Rasmussen P Vidal B Welinder L Bent-Hansen U Segaard T Deckert Evidence of changes in renal charge selectivity in patients with type I (insulin-dependent) diabetes mellitus Diabetologia 29 1986 634 639
139. Z Makita S Radoff EJ Rayfield Z Yang E Skolnik V Delany EA Friedman A Cerami H Vlassara Advanced glycosylation end products in patients with diabetic nephropathy N Engl J Med 325 1991 836 841
140. PJ Beisswenger Z Makita TJ Curphey LL Moore S Jean T Brinck-Johnsen R Bucala H Vlassara Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestation of renal and retinal disease in diabetes Diabetes 44 1995 824 829
141. JS Jensen K Borch-Johnsen T Deckert M Deckert G Jensen B Feldt-Rasmussen Reduced glomerular size and charge-selectivity in clinically healthy individuals with microalbuminuria Eur J Clin Invest 25 1995 608 614
142. A Kofoed-Eneevoldsen WJ Foyle M Fernandez JS Yudkin Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria: Relevance to cardiovascular disease Arterioscler Thromb Vasc Biol 16 1996 450 454
143. AV Sterpetti A Cucina F Napoli H Shafer A Cavallaro LS D'Angelo Growth factor release by smooth muscle cells is dependent on hemodynamic factors Eur J Vasc Surg 6 1992 636 638
144. BL Riser P Cortes X Zhao J Bernstein F Dumler RG Narins Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat J Clin Invest 90 1992 1932 1943
145. AM Malek GH Gibbons VJ Dzau S Izumo Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium J Clin Invest 92 1993 2013 2021
146. AM Malek IW Lee SL Alper S Izumo Regulation of endothelin-1 gene expression by cell shape and the microfilament network in vascular endothelium J Clin Invest 273 1997 C1764 C1774
147. D Shweiki A Itin D Soffer E Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
148. TK Yeo DR Senger HF Dvorak L Freter KT Yeo Glycosylation is essential for efficient secretion but not for permeability enhancing activity of vascular permeability factor Biochem Biophys Res Commun 179 1991 1568 1575
149. JM Heslen AI Branellec Y Pilatte P Land G Lagrue Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal change nephrotic syndrome Clin Exp Immunol 86 1991 157 162
150. K Maruyama S Tomizawa Y Seki H Arai T Kuroume Inhibition of vascular permeability factor production by cyclosporin in minimal change nephrotic syndrome Nephron 62 1992 27 30
151. E Morelli N Loon T Meyer W Peters B Meyer Effect of converting enzyme inhibition on barrier function in diabetic glomerulopathy Diabetes 39 1990 76 82
152. G Gambaro AO Cavazzana P Luzi A Piccoli A Borsatti G Crepaldi E Marchi AP Venturini B Baggio Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats Kidney Int 42 1992 285 291
153. B Myrup PM Hansen T Jensen A Kofoed-Enevoldsen B Feldt-Rasmussen J Gram C Kluft J Jespersen T Deckert Effect of low dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus Lancet 345 1995 421 422
154. R Nosadini MR Cipollina A Solini M Sambataro A Morocutti A Doria P Fioretto E Brocco B Muollo F Frigato Close relationship between microalbuminuria and insulin resistance in essential hypertension and non–insulin-dependent diabetes mellitus J Am Soc Nephrol 3 suppl 1 1992 S56 S63
155. A Mimran J Ribstein G DuCailar Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 23 1994 1018 1021
156. R Pontremoli A Sofia M Ravera C Nicoletta F Viazzi A Tirotta N Ruello C Tomolillo C Castello G Grillo G Sacchi G Deferrari Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC Study. Microalbuminuria: A Genoa Investigation on complications Hypertension 30 1997 1135 1143
157. SM Haffner MP Stern KK Gruber HP Hazuda BD Mitchell JK: Patterson Microalbuminuria . A marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10 1990 727 731
158. VM Campese S Bianchi R Bigazzi Association between hyperlipidemia and microalbuminuria in essential hypertension Kidney Int 56 suppl 7 1999 S-10 S-13
159. PA Metcalf JR Baker RK Scragg E Dryson AJ Scott CJ Wild Dietary nutrient intake and microalbuminuria in people at least 40 years old Clin Chem 39 1993 2191 2198
160. A Basdevant D Cassuto T Gibault J Raison B Guy-Grand Microalbuminuria and body fat distribution in obese subjects Int J Obes Relat Metab Disord 18 1994 806 811
161. GA Kaysen Hyperlipidemia of the nephrotic syndrome Kidney Int Suppl 3 1991 S8 S15
162. WF Keane JV St Peter BL Kasiske Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory? Kidney Int Suppl 42 1992 S134 S141
163. SR Newmark CF Anderson JV Donadio RD Ellefson Lipoprotein profiles in adult nephrotics Mayo Clin Proc 50 1975 359 366
164. ME Thomas AL Freestone JW Persaud Z Varghese JF Moorhead Raised lipoprotein(a) [Lp(a)] levels in proteinuric patients J Am Soc Nephrol 1 1990 344A (abstr)
165. I Karådi L Romics G Pålos J Domån I Kaszås A Hesz GM Kostner Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin Clin Chem 10 1989 2121 2123
166. AJ Jenkins JS Steel ED Janus JD Best Increased plasma apoprotein(a) levels in IDDM patients with microalbuminuria Diabetes 40 1991 787 790
167. H Kapelrud HJ Bangstad K Dahl-Jorgensen K Berg KF Hanssen Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria BMJ 303 1991 675 678
168. ER Seaquist FC Goetz S Rich J Barbosa Familiar clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy N Engl J Med 320 1989 1161 1165
169. JP Fauvel A Hadj-Aissa M Laville G Fadat M Labeeuw P Zech N Pozet Microalbuminuria in normotensives with genetic risk of hypertension Nephron 57 1991 375 376
170. B Grunfeld E Perelstein R Simsolo M Gimenez JC Romero Renal functional reserve and microalbuminuria in offspring of hypertensive parents Hypertension 15 1990 257 261
171. WB Kannel WP Castelli T Gordon Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study Ann Intern Med 90 1979 85 91
172. T Gordon WB Kannel WP Castelli TR Dawber Lipoproteins, cardiovascular disease and death. The Framingham Study Arch Intern Med 141 1981 1128 1131
173. AM Scanu Lipoprotein(a): A genetic risk factor for premature coronary heart disease JAMA 267 1992 3326 3329
174. J Willeit S Kiechl P Santer F Oberhollenzer G Egger E Jarosch A Mair Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: The Bruneck Study Stroke 26 1995 1582 1587
175. WF Keane Lipids and the kidney Kidney Int 46 1994 910 920
176. WF Keane BL Kasiske MP O'Donnel Y Kim Hypertension, hyperlipidemia and renal damage Am J Kidney Dis 21 suppl 2 1993 S43 S50
177. H Mulec SA Johnson S Bjorck Relationship between serum cholesterol and diabetic nephropathy Lancet 1 1990 1537 1538
178. JP Tolins BG Stone L Raij Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury Kidney Int 41 1992 1254 1261
179. T Al-Shebeb J Frohlich AB Magil Glomerular disease in hypercholesterolemic guinea pigs: A pathogenic study Kidney Int 33 1988 498 507
180. HJ Groene E Groene H Luthe MH Weber V Helmchen Induction of glomerular sclerosis by a lipid-rich diet in male rats Lab Invest 60 1989 433 446
181. WF Keane WS Mulcahy BL Kasiske Y Kim MP O'Donnell Hyperlipidemia and progressive renal disease Kidney Int Suppl 39 1991 S41 S48
182. BH Rovin LC Tan LDL stimulates mesangial fibronectin production and chemoattractant expression Kidney Int 43 1993 218 225
183. S Klahr G Schreiner I Ichikawa The progression of renal disease New Engl J Med 318 1988 1657 1666
184. LM Alderson G Endemann S Lindsey A Pronczuk RL Hoover KC Hayes LDL enhances monocyte adhesion to endothelial cells in vitro Am J Pathol 123 1986 334 342
185. R Pai MA Kirschenbaum VS Kamanna Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells Kidney Int 48 1995 1254 1262
186. E Ferrannini G Buzzigoli R Bonadonna MA Giorico M Oleggini L Graziadei R Pedrinelli L Brandi S Bevilacqua Insulin resistance in essential hypertension N Engl J Med 317 1987 350 357
187. AL Swislocki BB Hoffman GM Reaven Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension Am J Hypertens 2 1989 419 423
188. G Berglund B Larsson O Andersson O Larsson K Svardsudd P Bjorntorp L Wilhelmsen Body composition and glucose metabolism in hypertensive middle-aged males Acta Med Scand 200 1976 163 169
189. CE Mondon GM Reaven Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension Metabolism 37 1988 303 305
190. Y Yamori K Ohta M Ohtaka Y Nara R Horie A Ooshima Glucose tolerance in spontaneously hypertensive rats Jpn Heart J 19 1978 559 560
191. M Krotiewski K Mandroukas L Sjostrom L Sullivan H Wetterauist P Bjorntorp Effects of long-term physical training on body fat, metabolism and blood pressure in obesity Metabolism 28 1979 650 658
192. R Tedde LA Sechi A Marigliano A Pala L Scano Antihypertensive effects of insulin reduction in diabetic hypertensive patients Am J Hypertens 2 1989 163 170
193. I Zavaroni E Bonora M Pagliara E Dall'Aglio L Luchetti G Buonanno PA Bonati M Bergonzani L Gnudi M Passeri G Reaven Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance N Engl J Med 320 1989 702 706
194. JH Fuller MJ Shipley G Rose RJ Jarrett H Keen Coronary heart disease risk and impaired glucose tolerance. The Whitehall Study Lancet 1 1980 1373 1376
195. K Pyorala M Uusitupa M Laakso O Siitonen L Niskanen T Ronnemaa Macrovascular complications in relation to hyperinsulineamia in non–insulin-dependent diabetes mellitus Diabetes Metab 13 1987 345 349
196. TA Welbon K Wearne Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations Diabetes Care 2 1979 154 160
197. M Modan H Halkin S Almog A Lusky A Eshkol M Shefi A Shitrit Z: Fuchs Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance J Clin Invest 75 1985 809 817
198. E Eschwege JL Richard N Thibult P Ducimetiere JM Warnet JR Claude GE Rosselin Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later Horm Metab Res 15 1985 41 46
199. P Ducimetiere R Eschwege L Papoz JL Richard JR Claude G Rosselin Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population Diabetologia 19 1980 205 210
200. MP Stern SM Haffner Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease Arteriosclerosis 6 1986 123 130
201. S Bianchi R Bigazzi C Valtriani I Chiapponi G Sgherri G Baldari A Natali E Ferranini VM Campese Elevated serum insulin levels in patients with essential hypertension and microalbuminuria Hypertension 23 1994 681 687
202. S Bianchi R Bigazzi A Quinones Galvan E Muscelli G Baldari N Pecori D Ciociaro E Ferranini A Natali Insulin resistance in microalbuminuric hypertension: Sites and mechanism Hypertension 26 1995 789 795
203. 13C nuclear magnetic resonance spectroscopy N Engl J Med 322 1990 223 228
204. JP Felber E Ferranini A Golay HU Meyer D Theibaud B Churcod E Maeder E Jequier A DeFronzo Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes Diabetes 36 1987 1341 1350
205. J Woo CS Cockram R Swaminathan E Lau A Chan R Cheung Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects Int J Cardiol 37 1992 345 350
206. A Doria P Fioretto A Avogaro A Carraro A Morocutti R Trevisan F Frigato G Crepaldi GC Viberti R Nosadini Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension Am J Physiol 261 1991 684 691
207. R Nosadini A Semplicini P Fioretto L Lusiani R Trevisan V Donadon G Zanette GL Nicolosi V dall'Aglio D Zanuttini GC Viberti Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension Hypertension 18 1991 191 198
208. B Falkner H Kushner S Levison M Canessa Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension Hypertension 25 1995 1315 1321
209. RA Sicree PZ Zimmet HOM King JS Coventry Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over six years Diabetes 36 1987 179 186
210. MF Saad WC Knowler DJ Pettitt RG Nelson DM Mott PH Bennet The natural history of impaired glucose tolerance in the Pima Indians N Engl J Med 319 1988 1500 1506
211. L Mykkanen SM Haffner J Kuusisto K Pyoralea M Laakso Microalbuminuria precedes the development of NIDDM Diabetes 43 1994 552 557
212. SM Haffner MP Stern HP Hazuda BD Mitchell JK Patterson E Ferranini Parenteral history of diabetes is associated with increased cardiovascular risk factors Arteriosclerosis 9 1989 928 933
213. JH Medalie CM Papier U Goldbourt JB Herman Major factors in the development of NIDDM in 10,000 men Arch Intern Med 135 1975 811 817
214. JB McPhillips E Barret-Connor DL Wingard Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults Am J Epidemiol 131 1990 443 453
215. SM Haffner MP Stern HP Hazuda BD Mitchell JK Patterson Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263 1990 2893 2898
216. J Yip MB Mattock A Morocutti M Sethi R Trevisan G Viberti Insulin resistance in insulin-dependent diabetic patients with microalbuminuria Lancet 342 1993 883 887
217. L Groop A Ekstrand C Forsblom E Widen PH Groop AM Teppo J Eriksson Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 36 1993 642 647
218. L Niskanen M Laakso Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus Metabolism 42 1993 1541 1545
219. P Ferrari P Weidmann S Shaw D Giachino W Riesen Y Alleman G Heynen Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent Am J Med 91 1991 589 596
220. B Falkner S Hulmans J Tannembaum H Kushner Insulin resistance in young black men Hypertension 16 1990 706 711
221. Y Ohno H Suzuki H Yamakawa M Nakamura K Otsuka T Saruta Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: Possible role of disturbed calcium metabolism J Hypertens 11 1993 421 426
222. B Grunfeld M Balzareti M Romo M Gimenez R Gutman Hyperinsulinemia in normotensive offspring of hypertensive parents Hypertension 23 suppl I 1994 SI12 SI15
223. R Ross The pathology of atherosclerosis: An update N Engl J Med 314 1986 488 500
224. AB Cruz DS Amatuzio F Grande LJ Hay Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan diabetic dogs Circ Res 9 1961 39 43
225. RW Stout EL Bierman A Ross Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells Circ Res 36 1975 319 327
226. DM Larson CC Haudenschild Activation of smooth muscle cell outgrowth from BB/Wor rat aortas Diabetes 37 1988 1382 1385
227. L Capron J Jarnet S Kazandjian E Housset Growth-promoting effects of diabetes and insulin on arteries Diabetes 35 1986 973 978
228. MJ Oppenheumer K Sundquist EL Bierman Down-regulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I Diabetes 38 1989 117 122
229. J Nakao H Ito T Kanayasu SI Murota Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy 5,8,10,14 eicosatetraenoic acic and its modulation by elevated extracellular glucose levels Diabetes 34 1985 185 191
230. W Krone H Greten Evidence for post-transcriptional regulation by insulin of 3 hydroxy-3-methylglutaryl coenzyme A reductase and sterol synthesis in human mononuclear leucocytes Diabetologia 26 1984 366 369
231. R Stout Insulin stimulation of cholesterol synthesis by arterial tissue Lancet 2 1969 467 468
232. JW Sholey TW Meyer Control of glomerular hypertension by insulin administration in diabetic rats J Clin Invest 83 1989 1384 1389
233. RA DeFronzo CR Cooke R Andres GR Faloona PJ David The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man J Clin Invest 55 1975 845 855
234. M Baum Insulin stimulates volume absorption in the proximal convoluted tubule J Clin Invest 56 1987 335 340
235. NJ Christensen HJG Gundersen L Hegedus F Jacobsen CE Mogensen R Osterby E Vittinghus Acute effects of insulin on plasma noradrenaline and the cardiovascular system Metabolism 29 1980 1138 1145
236. JW Rowe JB Young KL Minaker AL Stevens J Pallotta L Landsberg Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man Diabetes 30 1981 219 225
237. J Hilsted NJ Christensen Dual effect of insulin on plasma volume and transcapillary albumin transport Diabetologia 35 1992 99 103
238. CE Mogensen NJ Christensen HJG Gundersen The acute effects of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion Diabetologia 18 1980 453 457
239. L Hedgeus NJ Christensen CE Mogensen HJG Gundersen Oral glucose increases urinary albumin excretion in normal subjects but not in insulin-dependent diabetics Scand J Clin Lab Invest 40 1980 479 482
240. K Nrgaard T Jensen B Feldt-Rasmussen Transcapillary escape rate of albumin in hypertensive patients with type I (insulin-dependent) diabetes mellitus Diabetologia 36 1993 57 61
241. B Feldt-Rasmussen Increased transcapillary escape of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria Diabetologia 29 1986 282 286
242. M Nannipieri L Rizzo A Rapuano A Pilo G Penno R Navalesi Increased transcapillary escape of albumin in microalbuminuric type II diabetic patients Diabetes Care 18 1995 1 9
243. JS Jensen Renal and systemic transvascular albumin leakage in severe atherosclerosis Arterioscler Thromb Vasc Biol 15 1995 1324 1329
244. HH Parving HA Jensen M Westrup Increased transcapillary escape rate of albumin and IgG in essential hypertension Scand J Lab Invest 37 1977 223 227
245. H-H Parving F Gyntelberg Transcapillary escape rate of albumin and plasma volume in essential hypertension Circ Res 33 1973 543 553
246. JS Jensen K Borch-Johnsen J Jensen B Feldt Rasmussen Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects Clin Sci 88 1995 629 633
247. J Hilsted NJ Christensen S Larsen Effect of catecholamines and insulin on plasma volume and intravascular mass of albumin in man Clin Sci 77 1989 149 155
248. JE Nestler CO Barlascini GA Tetrault MJ Fratkin JN Clore WG Blackard Increased transcapillary escape of albumin in nondiabetic men in response to hyperinsulinemia Diabetes 39 1990 1212 1217
249. C Catalano E Muscelli A Quinones Galvan S Baldi A Masoni I Gibb O Torffvit G Seghieri E Ferrannini Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects Diabetes 46 1997 868 875
250. R Pedrinelli O Giampietro F Carmassi E Melillo G Dell'Omo G Catapano E Matteucci R Talarico M Morale F De Negri V Di Bello Microalbuminuria and endothelial disfunction in essential hypertension Lancet 344 1994 14 18
251. CDA Stehouwer P Zellenrath BCP Polak GS Baarsma JJP Nauta AJM Donker GJH den Ottolander von Willebrand factor and development of diabetic nephropathy in insulin-dependent diabetes mellitus Diabetes 40 1991 971 976
252. JW Chen MA Gall M Deckert JS Jensen HH Parving Increased serum concentration of von Willebrand factor in non-insulin-dependent diabetic patients with and without diabetic nephropathy BMJ 311 1995 1405 1406
253. AD Baron H Stainberg G Brechtel A Johnson Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake Am J Physiol 266 1994 E248 E253
254. S Taddei A Virdis P Mattei A Natali E Ferrannini A Salvetti Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension Circulation 92 1995 2911 2918
255. A Natali S Taddei A Quinones Galvan S Camastra S Baldi S Frascerra A Virdis I Sudano A Salvetti E Ferrannini Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension Circulation 96 1997 849 855
256. S Taddei A Virdis P Mattei L Ghiadoni I Sudano P Arrighi A Salvetti Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients J Hypertens 13 1995 1003 1008
257. A Natali R Bonadonna D Santoro A Quinones Galvan S Baldi S Frascerra S Baldi C Palombo S Ghione E Ferrannini Insulin resistance and vasodilatation in essential hypertension. Studies with adenosine J Clin Invest 94 1994 1570 1576
258. U Sherrer D Randin P Vollender L Vollender P Nicod Nitric oxide release accounts for insulin's vascular effects in humans J Clin Invest 94 1994 2511 2515
259. JV Neel Diabetes melitus: A “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 14 1962 353 362
260. CN Hales DJ Barker Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty genotype hypothesis Diabetologia 35 1992 595 601
261. BM Brenner HS MacKenzie Nephron mass as a risk factor for progression of renal disease Kidney Int Suppl 63 1997 S124 S127
262. J Redon MA Gomez-Sanchez E Baldo MC Casal ML Fernandez A Miralles C Gomez-Pajuelo JL Rodicio LM Ruilope Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensive patients J Hypertens 9 suppl 6 1991 S148 S149
263. R Pedrinelli VD Bello G Catapano L Talarico F Materazzi G Santoro C Giusti F Mosca E Melillo M Ferrari Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in non diabetic atherosclerotic patients Arterioscler Thromb 13 1993 900 906
264. D Cerasola S Cottone G D'Ignoto L Grasso MT Mangano E Carapelle E Nardi G Andronico MA Fulantelli T Marcellino G Seddio Microalbuminuria as a predictor of cardiovascular damage in essential hypertension J Hypertens 7 suppl 6 1989 S332 S333
265. S Agewall B Persson O Samuelsson S Ljungman H Herlitz B Fageberg Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group J Hypertens 11 1993 461 469
266. R Bigazzi S Bianchi R Nenci D Baldari G Baldari VM Campese Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria J Hum Hypertens 9 1995 827 833
267. JT Salonen R Salonen Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscler Thromb 11 1991 1245 1249
268. JS Yudkin RD Forrest CA Jackson Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey Lancet 2 1988 530 533
269. EL Damsgaard A Froland OD Jorgensen CE Mogensen Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment Diabetologia 36 1993 1030 1036
270. J Kuusisto L Mykkanen K Pyorealea M Laakso Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease Circulation 9 1995 831 837
271. R Bigazzi S Bianchi D Baldari VM Campese Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension predicts J Hypertens 16 1998 1325 1333
272. A a Jager PJ Kostense HG Ruhe RJ Heine G Nijpels JM Dekker LM Bouter CDA Stehouwer Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects. Five-year follow-up of the Hoorn study Arterioscler Thromb Vasc Biol 19 1999 617 624
273. K b Borch-Johnsen B Feldt-Rasmussen S Strandgaard M Scroll JS Jensen Urinary albumin excretion: An independent predictor of ischemic heart disease Arterioscler Thromb Vasc Biol 19 1999 1992 1997
274. C Lydakis GYH Lip Microalbuminuria and cardiovascular risk Q Med J 91 1998 381 391
275. S Agewall J Wilkstrand S Ljungman H Herlitz B Fagerberg Does microalbuminuria predict cardiovascular events in non diabetic men with treated hypertension? Risk Factors Intervention Study Group Am J Hypertens 8 1995 337 342
276. P Palatini GR Graniero P Mormino M Mattarei F Sanzuol GB Cignacco S Gregori G Garavelli F Pegoraro G Maraglino A Bortolazzi V Accurso F Dorigatti F Graniero R Gelisio R Businaro O Vriz M Dal Fallo A Camarotto AC Pessina Prevalence and clinical correlates of microalbuminuria in Stage 1 hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST) study Am J Hypertens 9 1996 334 341
277. S Taddei A Virdis P Mattei C Ghiaboni I Sudano P Arrighi A Salvetti Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients J Hypertens 13 1995 1003 1008
278. P Gosling Microalbuminuria and cardiovascular risk: A word of caution J Hum Hypertens 12 1998 211 213
279. X Jiang SR Srinivasan B Radhakrishnamurthy ER Dalferes W Bao JS Berenson Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. The Bogalusa Heart Study Am J Hypertens 7 1994 794 800
280. RE Schmieder R Veelken CD Gatzka H Ruddel H Schachinger Predictors for hypertensive nephropathy: Results of seven years of follow-up in essential hypertension J Hypertens 13 1994 357 365
281. LM Ruilope C Campo F Rodriguez-Artalejo V Lahera R Garcia Robles JL Rodicio Blood pressure and renal function: Therapeutic implications J Hypertens 14 1996 1259 1263
282. 2 -microglobulin hyperexcretion in recent severe essential hypertension J Hypertens 1 1983 45 51
283. CM Erley U Haefele N Heyne N Braun T Risler Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs Hypertension 21 1993 810 815
284. M Laville C Doche JP Fauvel N Pozet A Hadj-Aissa P Zech Effect of beta-blockade on albumin excretion rate in essential hypertension Nephron 54 1990 183 184
285. M Hartford I Wendelhag G Berglund I Wallentin S Ljungman J Wikstrand Cardiovascular and renal effects of long-term antihypertensive treatment JAMA 259 1988 2553 2557
286. S Ljungman J Wikstrand M Hartford M Aurell G Lindstedt G Berglund Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension Am J Hypertens 6 1993 554 563
287. RE Schmieder H Ruddel H Schlebusch J Rockstroh H Schachinger W Schulte Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy Am J Hypertens 5 1992 318 321
288. B Persson OK Andersson M Wysocki T Hedner B Karlberg Calcium antagonism in essential hypertension: Effect on renal hemodynamics and microalbuminuria J Intern Med 213 1992 247 252
289. LM Ruilope V Lahera JM Alcazar M Praga C Campo JL Rodicio Randomly allocated study of the effects of standard therapy versus ACE inhibition on microalbuminuria in essential hypertension J Hypertens 12 suppl 4 1994 S59 S63
290. LR Krusell CK Christensen O Lederballe-Pedersen Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy Eur J Clin Pharmacol 30 1986 641 647
291. G De Venuto C Andreotti M Mattarei G Pegoretti Long-term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no sign of renal impairment J Hypertens 3 suppl 2 1985 S143 S145
292. S Bianchi R Bigazzi G Baldari VM Campese Microalbuminuria in patients with essential hypertension. Effects of an angiotensin-converting enzyme inhibitor and of a calcium channel blocker Am J Hypertens 4 1991 291 296
293. S Bianchi R Bigazzi G Baldari VM Campese Microalbuminuria in patients with essential hypertension: Effects of several antihypertensive drugs Am J Med 93 1992 525 528
294. R Bigazzi S Bianchi D Baldari G Sgherri G Baldari VM Campese Long-term effects of a converting-enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension Am J Hypertens 6 1993 108 113
295. MP Hermans SM Brichard I Colin P Borgies JM Ketelslegers AE Lambert Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients Am J Med 92 suppl 4 1992 S102 S107
296. GP Reams A Lau V Knaus JH Bauer Short and long-term effects of spirapil on renal hemodynamics in patients with essential hypertension J Clin Pharmacol 33 1993 348 353
297. JG Puig FA Mateos TH Ramos MP Lavilla MC Capitan A Gil Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors Am J Hypertens 7 1994 46 51
298. LJ Dominguez M Barbagallo W Kattah D Garcia J Sowers Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects Am J Hypertens 8 1995 808 814
299. JE Heeg PE DeJong GK van der Hem D de Zeeuw Reduction of proteinuria by converting enzyme inhibition Kidney Int 36 1989 272 279
300. A Remuzzi S Puntonieri C Battaglia T Bertani G Remuzzi Angiotensin-converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat J Clin Invest 85 1990 541 549
301. G Mayer RA Lafayette J Oliver WM Deen BD Myers TW Meyer Effects of angiotensin II receptor blockade on remnant glomerular permselectivity Kidney Int 43 1993 346 353
302. A Remuzzi B Malenchini C Battaglia T Bertani G Remuzzi Comparison of the effects of angiotensin-converting-enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MFW/Ztm rats Exp Nephrol 4 1996 19 25
303. A Remuzzi P Ruggenenti L Mosconi V Pata G Viberti G Remuzzi Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy J Nephrol 6 1993 36 43
304. A Remuzzi E Perticucci P Ruggenenti L Mosconi M Limonta G Remuzzi Angiotensin-converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy Kidney Int 39 1991 1267 1273
305. A Remuzzi A Schieppati G Battaglia G Remuzzi Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome Am J Kidney Dis 14 1989 170 177
306. TH Hostetter ME Rosemberg Hemodynamic effects of glomerular permselectivity Am J Kidney Dis 10 1990 24 27
307. V Bedogna E Valvo P Casagrande P Braggio C Fontanarosa F Dal Santo D Alberti G Maschio Effects of ACE inhibition in normotensive patients with incipient diabetic nephropathy Kidney Int 38 1990 101 107